Highlights from: The 29th Annual San Antonio Breast Cancer Symposium; San Antonio, TX; December 2006 - Bevacizumab combination regimens as first-line therapy of metastatic breast cancer: The NCCTG N0432 and XCALiBr trials

Jennifer Klem, Zachary Moore, Susan Peck, Debasish Tripathy, Joyce O'Shaughnessy

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)536-538
Number of pages3
JournalClinical Breast Cancer
Issue number7
StatePublished - 2007

ASJC Scopus subject areas

  • Cancer Research

Cite this